← Browse by Condition
Medical Condition

her2 positive malignancies

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT04684459 EARLY_Phase 1
Recruiting

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Enrollment
18 pts
Location
China
Sponsor
Sichuan University
View Trial →